Hamish Allen
7Patents
5h-index
28Co-inventors
59Inventor score
Filing activity: Aug 13, 1996 → Jun 3, 2009
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9035027B2 | Dual variable domain immunoglobulins and uses thereof | Emerging Cross-Sectional Technologies | 41 | Active |
| US5919790A | Hydroxamate inhibitors of interleukin-1.beta. converting enzyme | Chemistry; Metallurgy | 25 | Expired |
| US5932549A | N-substituted glutamic acid derivatives with interleukin-1.beta. converting enzyme inhibitory activity | Physics | 20 | Expired |
| US5744451A | N-substituted glutamic acid derivatives with interleukin-1 .beta. converting enzyme inhibitory activity | Physics | 11 | Expired |
| US6316415A | Sulfonamide interleukin-1.beta. converting enzyme inhibitors | Chemistry; Metallurgy | 11 | Expired |
| US6100445A | Transgenic knockout mouse having functionally disrupted interleukin-1.beta. converting enzyme gene | Human Necessities | 2 | Expired |
| US6083981A | Sulfonamide substituted aspartic acid interleukin-1.beta. converting enzyme inhibitors | Chemistry; Metallurgy | 2 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.